Glaxosmithkline Plc Adrf - GSK (GSK)

CUSIP: 37733W105

Q4 2023 13F Holders as of 31 Dec 2023

Share change
-24,917
SEC-reported price per share
$37.06
Number of holders
8
Value change
-$923,395
Number of sells
4

Security key

37733W105

Report period

Q4 2023

Institutions

8

Top holders

8

Ownership snapshot

Top reported holders of GSK - Glaxosmithkline Plc Adrf - GSK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
DODGE & COX
Disclosed value leader
DODGE & COX
Comparable rows
0/15
Latest evidence
30 Sep 2023
13F Highest disclosed value: $2,511,442,884 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

DODGE & COX has the largest disclosed position value at $2.51B.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens DODGE & COX's linked filing trail.
Disclosed position value Top 5
DODGE & COX $2.51B
FMR LLC $656.11M
Fisher Asset Management, LLC $493.01M
PRICE T ROWE ASSOCIATES INC /MD/ $462.8M
JTC Employer Solutions Trustee Ltd $451.11M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
DODGE & COX
13F
Company
13F
—
denominator unverified
$2,511,442,884
69,281,183 shares
— 30 Sep 2023
FMR LLC
13F
Company
13F
—
denominator unverified
$656,107,356
18,099,513 shares
— 30 Sep 2023
Fisher Asset Management, LLC
13F
Company
13F
—
denominator unverified
$493,014,271
13,600,393 shares
— 30 Sep 2023
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$462,798,000
12,766,825 shares
— 30 Sep 2023
JTC Employer Solutions Trustee Ltd
13F
Company
13F
—
denominator unverified
$451,112,000
12,444,460 shares
— 30 Sep 2023
PRIMECAP MANAGEMENT CO/CA/
13F
Company
13F
—
denominator unverified
$437,130,412
12,058,770 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
8
Shares
1,271,429
Rows available
8
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q2 2026 Across Filers

Q2 2026 holders
4
Q4 2023 holders
8
Holder diff
4
Investor Q2 2026 Shares Q4 2023 Shares Share Diff Share Chg % Q2 2026 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .